Navigation Links
MarketsandMarkets Partners With IIR USA for Their Event 'Advanced Biomarker Strategies in Oncology Drug Development'

DALLAS, February 1 /PRNewswire/ -- The organizers of the Annual Partnerships in Clinical Trials and Central Labs events present Advanced Biomarker Strategies in Oncology Drug Development. The conference is organized at the Grand Hyatt, San Francisco from February 4-5, 2010. This event is FREE for executives from the biotech and pharmaceutical industries.

This two-day program focuses exclusively on the latest developments in oncology biomarkers. It provides an opportunity to interact with the leaders in clinical R&D, oncology, drug development, and translational research. The program aims to deliver and develop solutions, industry standards, and practical applications for biomarker development and validation. This unique program is the first of our three part Target Clinical Trials Series, delivering therapeutic-specific strategies to facilitate execution of successful clinical trials.

For more information on this event, please visit

For more information on the Target Clinical Trial Series, visit

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at

The Global Biomarker Market report published by MarketsandMarkets analyzes the global biomarker tools and services markets over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker market; and evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.

The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014. Market growth is driven mainly by the high demand for biomarkers in the field of drug discovery; from the increasing demand from the baby boomer generation in the U.S.; and from Asia's emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers.


The report analyzes the global biomarker market into the following segments:

    - Tools Market-(pregenomic biomarkers and technologies, post
      genomic biomarkers and technologies, imaging biomarkers, and others)

    - Services Market-(pre- and post-clinical biomarker services,
      sample preparation, mirna analysis, and others)

    - Application Market-(diagnosis, and drug development and discovery)

    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

SOURCE MarketsandMarkets

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets Partners with the 9th Annual ePharma Summit to be Held on February 8 -10, 2010
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
11. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):